after Initiation of Treatment with Elexacaftor/Tezacaftor/Ivacaftor
Richard De Vuyst, MD1; Charissa W. Kam, PharmD, BCPPS, CPP2; Cameron J. McKinzie, PharmD, BCPPS, BCPS, CPP2; and Charles R. Esther, Jr., MD, PhD1
1Pediatric Pulmonology, University of North Carolina at Chapel Hill, Chapel Hill North Carolina, USA and2Department of Pharmacy, University of North Carolina Children’s Hospital, Chapel Hill North Carolina, USA.